The role of viral infections in the natural history of asthma

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 2, 2000, Pages 201-212

  Gern, James E ^a   Busse, William W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Asthma; Respiratory syncytial virus; Rhinovirus; Virus

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; VIRUS INFECTION; VIRUS REPLICATION; WHEEZING;

EID: 0033836306     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.108604     Document Type: Article

References (122)

1. Asthma and wheezing in the first six years of life
2. Maturation of immune responses at the beginning of asthma
3. Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human T-H cell lines following stimulation with RS virus and RS virus proteins
4. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins
5. Activation of antiviral protein kinase leads to immunoglobulin E Class switching in human B cells
6. Influenza A virus infection increases IgE production and airway responsiveness in aerosolized antigen-exposed mice
7. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
8. Respiratory infections in the first year of life in children at risk of developing atopy
9. RSV and chronic asthma
10. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy
11. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis
12. High levels of eosinophilic cationic protein in wheezing infants predict the development of asthma
13. Nasopharyngel eosinophil cationic protein in bronchiolitis - Relation to viral findings and subsequent wheezing
14. Cellular immunity is activated and a TH-2 response is associated with early wheezing in infants after bronchiolitis
15. Differential immune responses to acute lower respiratory illnesses in early life and subsequent development of persistent wheezing and asthma
16. Skin test reactivity and number of siblings
17. Hay fever, hygiene, and household size
18. Childhood antecedents of allergic sensitization in young British adults
19. The environmental predictors of allergic disease
20. The inverse association between tuberculin responses and atopic disorder
21. Measles and atopy in Guinea-Bissau
22. Measles history and atopic diseases: A population based cross-sectional study
23. Early childhood infection and atopic disorder
24. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus
25. Day care centers and respiratory health
26. Lower respiratory illness, recurrent wheezing, and day care attendance
27. Exposure to siblings and day care during infancy and the subsequent development of asthma and frequent wheeze
28. Viruses as precipitants of asthmatic attacks in children
29. Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction
30. Comparison of standard virology and PCR in diagnosis of rhinovirus and respiratory syncytial virus infections in nasal aspirates from children hospitalized with wheezing illness and bronchiolitis
31. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children
32. Respiratory viruses and exacerbations of asthma in adults
33. Respiratory tract viral infections in inner-city asthmatic adults
34. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses
35. The relationship between upper respiratory infections and hospital admissions for asthma: A time trend analysis
36. Respiratory infections and the autumn increase in asthma morbidity
37. Risk factors for acute wheezing in infants in infants and children: Viruses, passive smoke, and IgE antibodies to inhalant allergens
38. Differences between asthma exacerbations and poor asthma control
39. Rhinovirus-16 colds in healthy and in asthmatic subjects: Similar changes in upper and lower airways
40. Experimental Rhinovirus 16 infections causes variable airway obstruction in subjects with atopic asthma
41. Clinical manifestations of respiratory tract infections due to respiratory syncytial virus and rhinoviruses in hospitalized children
42. Respiratory viral infection in childhood. A survey in general practice, Roehampton 1967-1972
43. The Tecumseh study of respiratory illness II. Patterns of occurrence of infection with respiratory pathogens
44. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: Prospective cohort study
45. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice
46. Sudden death of an infant with rhinovirus infection complicating bronchial asthma: Case report
47. Lower airway inflammation during rhinovirus colds in normal and in asthmatic subjects
48. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils
49. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells
50. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection
51. Detection of rhinovirus RNA in lower airway cells during experimentally-induced infection
52. State of the art: Virus-induced airway hyperresponsiveness and asthma
53. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo
54. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects
55. Experimental rhinovirus infection in volunteers
56. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects
57. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects
58. The effects of rhinovirus infections on allergic airway responses
59. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions
60. Delayed onset of rhinovirus (RV)-16 common cold in allergic rhinitic subjects primed with nasal allergen challenges
61. Upper airway response in ragweed-primed and unprimed adult subjects during experimental infection with influenza A (FLU) virus
62. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus
63. Rhinovirus 39 infection in allergic and nonallergic subjects
64. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection
65. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds
66. Distinct types of lung disease caused by functional subsets of antiviral T cells
67. Rhinovirus-induced peripheral blood mononuclear cell responses and outcome of experimental infection in allergic subjects
68. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds
69. Kinins are generated during experimental rhinovirus colds
70. Interleukin-11: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness
71. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds
72. Effect of experimental rhinovirus 16 colds on airway hyper-responsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo
73. Virus-induced airway hyperresponsiveness in the guinea pig can be transferred by bronchoalveolar cells
74. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus
75. CD4+ T-cells clear virus but augment disease in mice infected with respiratory syncytial virus - Comparison with the effects of CD8+ T-cells
76. Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness
77. Infection of human respiratory submucosal glands with rhinovirus: Effects on cytokine and ICAM-1 production
78. Localization of rhinovirus replication in vitro with in situ hybridization
79. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization
80. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization
81. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation
82. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: Role of NF-κB
83. The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells
84. RANTES, macrophage-inhibitory protein 1α, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children
85. Nasal cytokine production in viral acute upper respiratory infection of childhood
86. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing
87. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils
88. RANTES: A novel mediator of allergic inflammation?
89. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections
90. Kinins are generated in nasal secretions during natural rhinovirus colds
91. A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers
92. Rhinovirus infection induces mucus hypersecretion
93. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells
94. Control of mucin transcription by diverse injury-induced signaling path-ways
95. Epidermal growth factor system regulates mucin production in airways
96. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection
97. In vitro incubation with influenza virus primes human polymorphonuclear leukocyte generation of superoxide
98. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors
99. Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children
100. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection
101. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects
102. Eosinophils bind rhinovirus and activate virus-specific T cells
103. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism
104. Nasal secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection
105. Rhinovirus enters but does not replicate inside monocytes and airway macrophages
106. 2-interferon
107. The role of lymphocytes in allergic disease
108. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
109. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells
110. Cytotoxic T lymphocyte memory: Role in cross-protective immunity against influenza?
111. Rhinovirus-specific T cells recognize both shared and serotype-restricted viral epitopes
112. Characterization of the T cell response to human rhinovirus in children: Implications for understanding the immunopathology of the common cold
113. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line
114. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects
115. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10
116. Diminished IL-10 production in subjects with allergy after infection with influenza A virus
117. Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: A potential mechanism of symptom resolution
118. Muscarinic receptor dysfunction in asthma
119. Virus-induced airway hyperresponsiveness: Role of inflammatory cells and mediators
120. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection
121. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection - A randomized clinical trial
122. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease